This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: New Mexico Technical Research Foundation. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Gabriel Avilucea
Introduction
Gabriel Avilucea is a notable inventor based in Socorro, New Mexico. He has made significant strides in the field of pharmaceuticals, particularly in cancer treatment. His work focuses on addressing the challenges posed by drug-resistant cancer.
Latest Patents
Avilucea holds a patent for the "Treatment of drug-resistant cancer with 2-aryl-2-(3-indolyl) acetohydroxamates." This patent encompasses a pharmaceutical composition, a method of producing the same, and a method of providing cancer therapy. The composition includes a pharmaceutically acceptable excipient or carrier and a compound Formula 3, or a pharmaceutically acceptable salt or prodrug thereof.
Career Highlights
Gabriel Avilucea is associated with the New Mexico Technical Research Foundation, where he contributes to innovative research and development in the pharmaceutical sector. His dedication to improving cancer therapies has positioned him as a valuable asset in the field.
Collaborations
Avilucea has worked alongside talented colleagues, including Alexander V Akensov and Snezna Rogelj. Their collaborative efforts enhance the research environment and foster innovation.
Conclusion
Gabriel Avilucea's contributions to cancer treatment through his patent and work at the New Mexico Technical Research Foundation highlight his commitment to advancing medical science. His innovative approach to tackling drug-resistant cancer is commendable and reflects the potential for future breakthroughs in the field.